Cargando…
IL-35: A Novel Immunomodulator in Hepatitis B Virus-Related Liver Diseases
Chronic hepatitis B virus (HBV) infection is a risk factor for liver cirrhosis (LC) and hepatocellular carcinoma (HCC), however, little is known about the mechanisms involved in the progression of HBV-related diseases. It has been well acknowledged that host immune response was closely related to th...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990793/ https://www.ncbi.nlm.nih.gov/pubmed/33777929 http://dx.doi.org/10.3389/fcell.2021.614847 |